The Health Resources and Services Administration announced a new proposal to allow rebate models in the 340B drug pricing program, marking its second attempt in 2026 after an earlier effort failed. The proposal would change how covered entities receive 340B discounts, moving from upfront discounts to post-purchase rebates. Hospital associations immediately opposed the plan, arguing it would create cash flow problems and administrative burdens for safety-net providers. If finalized, the rebate model could affect how Medicaid providers, particularly disproportionate share hospitals and federally qualified health centers, manage pharmaceutical costs.
Why it mattersMany Medicaid providers rely on 340B savings to fund uncompensated care and patient services, and a shift to rebates could strain their operating cash flow and increase administrative costs.
Pharmacy
The "One Big Beautiful Bill Act" (HR 1), enacted in July 2025, imposed substantial Medicaid funding reductions and new administrative requirements. In Maine, approximately 31,000 enrollees are projected to lose coverage due to these administrative burdens. Those losing coverage are expected to shift to charity care at hospitals. The changes threaten financial stability for rural hospitals and local economies dependent on Medicaid reimbursement.
Why it mattersState Medicaid agencies and rural hospitals face enrollment losses and uncompensated care increases from new federal administrative requirements that took effect in 2025.
Finance · Managed Care
The Rural Emergency Hospital (REH) designation, created by Congress to stabilize small rural hospitals through Medicare payments for emergency and outpatient services without inpatient beds, is now threatened by provisions in the One Big Beautiful Bill Act. While some hospitals have successfully converted to the REH model to remain operational, others closed before or after conversion. The law's impact on REH payment rates and eligibility remains unclear as CMS develops implementation guidance. State Medicaid agencies and managed care plans in rural service areas face potential network adequacy challenges if REH facilities close or lose viability.
Why it mattersChanges to REH sustainability directly affect Medicaid network adequacy in rural counties where these facilities often represent the only local emergency and outpatient care access point for managed care enrollees.
Managed Care
HHS Secretary Robert F. Kennedy Jr. stated in a CNN interview that President Trump has directed him to investigate perceived links between autism and vaccines. Kennedy confirmed the Wall Street Journal's reporting on the matter. The statement signals potential federal review of vaccine policy and safety monitoring under the current administration. No timeline or specific investigative framework has been announced.
Why it mattersFederal vaccine policy changes could affect Medicaid's EPSDT benefit requirements, VFC program administration, and state immunization coverage mandates that affect pediatric managed care contracts.
Maternal · CHIP · Managed Care
CMS finalized its fiscal year 2027 Inpatient Prospective Payment System (IPPS) rule on July 31, establishing a 2.3% payment rate increase for acute care and long-term care hospitals. The rule introduces the first mandatory, nationwide episode-based payment model for joint replacement procedures covering knee, hip, and ankle replacements. The rule takes effect October 1, 2026 (FY 2027 start). This matters for Medicaid because many state programs base their hospital payment rates on Medicare methodologies, and the bundled payment model could influence state approaches to managing orthopedic services under managed care and fee-for-service arrangements.
Why it mattersState Medicaid programs that benchmark hospital rates to Medicare or contract with hospitals serving dual-eligible beneficiaries will see immediate reimbursement impacts, and the mandatory bundled payment model may accelerate state adoption of similar episode-based payment approaches for orthopedic services.
Managed Care · Finance
CMS released the CY 2027 Physician Fee Schedule proposed rule restricting remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) under Medicare. The proposal would prohibit outsourcing of RPM/RTM services and revise reimbursement methodology, reversing 2026 expansions that lowered data-transmission thresholds and added new billing codes. The proposed changes would take effect January 1, 2027 if finalized. State Medicaid agencies that follow Medicare payment policies or allow RPM under managed care contracts may face operational and reimbursement changes if states align telehealth coverage with Medicare rules.
Why it mattersMedicaid managed care plans that reimburse RPM based on Medicare fee schedules or cover RPM for chronic conditions would need to assess contract language, payment rates, and vendor relationships if states adopt similar restrictions.
Managed Care
HHS issued a notice announcing a revised 340B Rebate Model Pilot Program that allows qualifying drug manufacturers to use rebates rather than upfront discounts for certain 340B-eligible drugs. The pilot is limited to drugs included on the CMS Medicare Drug Price Negotiation Selected Drug Lists for 2026 and 2027. Manufacturers must submit participation plans to HRSA by August 24, 2026, with approval decisions by September 24, 2026, and approved models taking effect January 1, 2027. The AHA opposes the pilot, citing concerns about administrative burdens, cash-flow disruptions, and compliance costs for hospitals serving vulnerable populations, and is considering legal options to block implementation.
Why it mattersThe pilot will impose new administrative and financial burdens on 340B covered entities, particularly safety-net hospitals, by shifting from upfront discounts to rebates for Medicare-negotiated drugs, affecting cash flow and potentially reducing resources available for patient care.
Pharmacy
On Medicaid's 61st anniversary, advocacy groups are raising concerns about potential funding cuts in budget proposals from the Trump administration. The warnings come as beneficiaries like 55-year-old Ivon Meneses rely on Medicaid for coverage of chronic conditions including asthma and diabetes. Advocates are highlighting the program's role as a safety net and the potential impact of federal budget actions on coverage and access. The timing of these warnings coincides with the program's July 30th anniversary, drawing attention to proposed changes that could affect state Medicaid budgets and beneficiary eligibility.
Why it mattersFederal budget proposals affecting Medicaid funding levels directly impact state program financing, managed care capitation rates, and coverage decisions for 90+ million beneficiaries.
Finance · Managed Care
CMS issued a final rule increasing Medicare inpatient payment rates by a net 2.3% for FY 2027, reflecting a 3.2% market basket increase offset by a 0.9% productivity adjustment. The rule adds $2.9 billion in total hospital payments, including $228 million in DSH and uncompensated care payments and $779 million in new technology payments. The rule expands the Comprehensive Care for Joint Replacement bundled payment model nationwide starting January 1, 2028, making it mandatory for most acute care hospitals with accountability for spending and quality during inpatient stays and 90 days post-discharge. Changes to quality reporting programs include eight new measures for the Inpatient Quality Reporting Program and electronic prior authorization requirements extending to medical benefit drugs beginning in 2028.
Why it mattersWhile focused on Medicare rates, these payment policies and bundled payment expansions often signal broader trends that influence Medicaid rate-setting methodologies, supplemental payment programs, and state adoption of similar value-based care models.
Finance · Managed Care
The Trump administration, through HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz, is attributing a significant decline in Affordable Care Act marketplace enrollment primarily to fraud prevention efforts rather than rising premiums. The administration's position contrasts with evidence that premium increases have driven many enrollees to drop coverage. This framing has implications for how federal officials justify enrollment declines and potential future policy decisions around marketplace subsidies and eligibility verification. The dispute centers on whether coverage losses stem from legitimate fraud detection or affordability barriers created by higher premiums.
Why it mattersThe administration's rationale for ACA enrollment declines could shape future federal approaches to Medicaid expansion, marketplace subsidies, and eligibility verification procedures that affect coverage continuity for dual-eligible and churning populations.
Managed Care · Finance